Company: IONQ
Filing Date: 2025-10-10
Form Type: 424B5
Source: 0001193125-25-236448
Chunk: 16

Company: IonQ, Inc.
Filing Date: 2025-10-10
Form: 424B5
Chunk 16
---
arrants may be adjusted in certain circumstances, including in the event of certain dividends, certain distributions of assets and forward or reverse splits of our shares of our
common stock.

Exercise limitations

A holder will
not have the right to exercise any portion of a Warrant if the holder (together with its affiliates) would beneficially own in excess of 4.99% of the total number of issued and outstanding common stock immediately after giving effect to such
exercise.

Antidilution and other adjustments

The
exercise price of the Series B Warrants and the number of shares of common stock issuable upon exercise of the Series B Warrants is subject to appropriate adjustment in the event of certain stock dividends and distributions, stock splits, stock
combinations, reclassifications or similar events affecting our shares of common stock, as well as upon any distribution of assets, including cash, stock or other property, to holders of our common stock.

The exercise price of the Pre-funded Warrants and the number of shares of common stock issuable upon exercise of the Pre-funded Warrants is subject to appropriate adjustment in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications or similar events affecting our shares of
common stock, provided that the exercise price of the Pre-funded Warrants will not be adjusted below the par value per share of our common stock. The holders of
Pre-funded Warrants have the right to participate on an as-exercised basis in certain distributions to our holders of our common stock.

Fundamental transactions

Under the Warrant Agreement for
the Series B Warrants, we have agreed that upon consummation of each Fundamental Transaction, if, upon such consummation, had a Series B Warrant been exercised immediately prior to such Fundamental Transaction (without regard to any limitations
on the exercise of a Series B Warrant), the holder would have been entitled to receive shares of common stock (or its equivalent) of the successor entity (such entity, as further defined in the Warrant Agreement, the “Successor
Entity”) or such other securities, cash, assets or other property, as applicable, the Successor Entity shall deliver to the holder confirmation that there shall be issued upon exercise of a Series B Warrant at any time after the
consummation of such Fundamental Transaction, in lieu of the shares of common stock (or other securities, cash, assets or other property, subject to certain exceptions) issuable upon the exercise of a Series B Warrant prior to such Fundamental